BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38095986)

  • 1. Emerging role of miR-320a in lung cancer: a comprehensive review.
    Mohanta A; Kumar RR; Singh RK; Mandal S; Yadav R; Khatkar R; Sharma U; Uttam V; Rana MK; Rana AP; Jain A
    Biomark Med; 2023 Sep; 17(18):767-781. PubMed ID: 38095986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway.
    Zhao W; Sun Q; Yu Z; Mao S; Jin Y; Li J; Jiang Z; Zhang Y; Chen M; Chen P; Chen D; Xu H; Ding S; Yu Z
    Gene; 2018 Sep; 670():31-37. PubMed ID: 29803922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis.
    Zhang Z; Li X; Sun W; Yue S; Yang J; Li J; Ma B; Wang J; Yang X; Pu M; Ruan B; Zhao G; Huang Q; Wang L; Tao K; Dou K
    Cancer Lett; 2017 Jul; 397():33-42. PubMed ID: 28288874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-320a-containing exosomes from human umbilical cord mesenchymal stem cells curtail proliferation and metastasis in lung cancer by binding to SOX4.
    Xie H; Wang J
    J Recept Signal Transduct Res; 2022 Jun; 42(3):268-278. PubMed ID: 34096448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of microRNA-320a promotes proliferation and invasion of non-small cell lung cancer cells by increasing VDAC1 expression.
    Zhang G; Jiang G; Wang C; Zhong K; Zhang J; Xue Q; Li X; Jin H; Li B
    Oncotarget; 2016 Aug; 7(31):49470-49480. PubMed ID: 27304056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-320a effectively suppresses lung adenocarcinoma cell proliferation and metastasis by regulating STAT3 signals.
    Lv Q; Hu JX; Li YJ; Xie N; Song DD; Zhao W; Yan YF; Li BS; Wang PY; Xie SY
    Cancer Biol Ther; 2017 Mar; 18(3):142-151. PubMed ID: 28106481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-320a is associated with cisplatin resistance in lung adenocarcinoma and its clinical value in non-small cell lung cancer: A comprehensive analysis based on microarray data.
    Lu M; Hu C; Wu F; Shu L; Pan Y; Liu X; Liu P; Ma F; Deng C; Huang M
    Lung Cancer; 2020 Sep; 147():193-197. PubMed ID: 32731058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA hsa_circ_0012673 facilitates lung cancer cell proliferation and invasion via miR-320a/LIMK18521 axis.
    Qin H; Liu J; Du ZH; Hu R; Yu YK; Wang QA
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1841-1852. PubMed ID: 32141553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZEB1 induces non-small cell lung cancer development by targeting microRNA-320a to increase the expression of RAD51AP1.
    Wang H; Dong H; Qiao L; Wu Y; Wu B; Jin X
    Exp Cell Res; 2021 Aug; 405(2):112687. PubMed ID: 34097859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of miR-320a-3p by gold nanoparticles combined with photothermal therapy for directly targeting Sp1 in lung cancer.
    Peng J; Wang R; Sun W; Huang M; Wang R; Li Y; Wang P; Sun G; Xie S
    Biomater Sci; 2021 Sep; 9(19):6528-6541. PubMed ID: 34582541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicle encapsulated microRNA-320a inhibits endometrial cancer by suppression of the HIF1α/VEGFA axis.
    Zhang N; Wang Y; Liu H; Shen W
    Exp Cell Res; 2020 Sep; 394(2):112113. PubMed ID: 32473223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p100 functions as a metastasis activator and is targeted by tumor suppressing microRNA-320a in lung cancer.
    Xing A; Pan L; Gao J
    Thorac Cancer; 2018 Jan; 9(1):152-158. PubMed ID: 29159900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin inhibits ovarian cancer progression by regulating circ-PLEKHM3/miR-320a/SMG1 axis.
    Sun S; Fang H
    J Ovarian Res; 2021 Nov; 14(1):158. PubMed ID: 34784955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-320a regulates cell proliferation and apoptosis in multiple myeloma by targeting pre-B-cell leukemia transcription factor 3.
    Lu Y; Wu D; Wang J; Li Y; Chai X; Kang Q
    Biochem Biophys Res Commun; 2016 May; 473(4):1315-1320. PubMed ID: 27086852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-320a enhances LRWD1 expression through the AGO2/FXR1-dependent pathway to affect cell behaviors and the oxidative stress response in human testicular embryonic carcinoma cells.
    Lin YH; Su CH; Chen HM; Wu MS; Pan HA; Chang CN; Cheng YS; Chang WT; Chiu CC; Teng YN
    Aging (Albany NY); 2024 Feb; 16(4):3973-3988. PubMed ID: 38385979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma.
    Costa C; Indovina P; Mattioli E; Forte IM; Iannuzzi CA; Luzzi L; Bellan C; De Summa S; Bucci E; Di Marzo D; De Feo M; Mutti L; Pentimalli F; Giordano A
    Cell Death Dis; 2020 Sep; 11(9):748. PubMed ID: 32929059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3.
    Sun L; Liu B; Lin Z; Yao Y; Chen Y; Li Y; Chen J; Yu D; Tang Z; Wang B; Zeng S; Fan S; Wang Y; Li Y; Song E; Li J
    Mol Cancer; 2015 Apr; 14():96. PubMed ID: 25924850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel circCLK3/miR-320a/FoxM1 axis promotes cervical cancer progression.
    Hong H; Zhu H; Zhao S; Wang K; Zhang N; Tian Y; Li Y; Wang Y; Lv X; Wei T; Liu Y; Fan S; Liu Y; Li Y; Cai A; Jin S; Qin Q; Li H
    Cell Death Dis; 2019 Dec; 10(12):950. PubMed ID: 31831728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA TUG1 promotes bladder cancer malignant behaviors by regulating the miR-320a/FOXQ1 axis.
    Tan J; Liu B; Zhou L; Gao J; Wang XK; Liu Y; Wang JR
    Cell Signal; 2022 Mar; 91():110216. PubMed ID: 34920123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer.
    Zhang Y; He X; Liu Y; Ye Y; Zhang H; He P; Zhang Q; Dong L; Liu Y; Dong J
    Oncol Rep; 2012 Mar; 27(3):685-94. PubMed ID: 22134529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.